Immune Checkpoint Inhibitor-Induced Gastrointestinal Toxicity: The Opinion of a Gastroenterologist

Immune checkpoint inhibitors (ICIs) are currently an important component of the standard first-line treatment for many neoplasms. Some guidelines recommend ICIs as adjuvant treatment. With their increased use, the incidence of associated immune-mediated adverse reactions will also increase. A signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Macovei Oprescu, Anca, Tulin, Raluca, Slavu, Iulian, Venter, Dana Paula, Oprescu, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711857/
https://www.ncbi.nlm.nih.gov/pubmed/34976532
http://dx.doi.org/10.7759/cureus.19945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711857/
https://www.ncbi.nlm.nih.gov/pubmed/34976532
http://dx.doi.org/10.7759/cureus.19945

Ejemplares similares